Sensome is a France-based startup specializing in Health Care and Medical Devices, founded in 2014. The company's innovative microsensing technology and predictive algorithms enable real-time tissue analysis during surgical procedures. Its proprietary Clotild® Smart Guidewire System, developed in collaboration with ASAHI INTECC, has applications in identifying cancerous lung tumors, characterizing clots in ischemic stroke, and peripheral vascular disease. Sensome's groundbreaking approach is based on electrical impedance spectroscopy, allowing for comprehensive tissue analysis. Their recent €8.00M Series B investment on January 12, 2020, attracted funding from leading investors such as IDInvest Partners, Kurma Partners, BNP Paribas Developpement, Asahi Intecc USA, Inc., and the Paris-Saclay Seed Fund. With its EN ISO 13485:2016 certification, Sensome is poised to make significant strides in revolutionizing intra-operative tissue analysis.
Sensome
Sensitive Medical Devices
France
39 employees
Series B
Total: $16.72M
Health Care, Medical Devices
General Information
Get notified when Sensome moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track Sensome
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
France Market
Health Care
About Sensome
Taxonomy: Connected Objects, MedTech, Neurovascular, Remote Monitoring Technology, Vascular Access Devices, Implantable Devices, Electrical Impedance Spectroscopy, Predictive Algorithms, Ischemic Stroke, Peripheral Vascular Disease, Biological Tissue Analysis, Guidewire Technology, ISO 13485 Certification, Intra-operative Tissue Analysis
Services & Products
Target Customers
Funding Rounds & Investors (6)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series B | •••••• | 5 |
|
12 Jan 2020 |
| Seed Round | •••••• | 2 |
|
11 Jun 2018 |
| Seed Round | •••••• | 3 |
|
10 Jul 2017 |
| Seed Round | •••••• | 1 |
|
09 Nov 2015 |
| Pre Seed Round | •••••• | 1 |
|
19 Feb 2015 |
Sensome Alternatives & Competitors
ViOptix has developed the proprietary breakthrough T.Ox Tissue Oximetry technology which enables non...
Innovative solutions for life-saving medical technologies to combat coronary and vascular diseases w...
A neuro-interventional medical device pioneer w aim of redefining the therapeutic & preventive parad...
vs
MIVI Neuroscience, Inc
FAQ About Sensome
Don't just browse. Track.
Signal Tracker monitors Sensome and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.